Robert Daniel Casale insider trades: Adams Respiratory Therapeutics (ARXT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 26, 2007 | ARXT | ↓ Sell | 3,000 | $59.68 | $179K | Direct | Dec 27, 2007 (1d) |
| Nov 26, 2007 | ARXT | ↓ Sell | 3,000 | $42.18 | $127K | Direct | Nov 26, 2007 (0d) |
| Oct 25, 2007 | ARXT | ↓ Sell | 3,000 | $40.57 | $122K | Direct | Oct 25, 2007 (0d) |
| Sep 25, 2007 | ARXT | ↓ Sell | 3,000 | $38.26 | $115K | Direct | Sep 26, 2007 (1d) |
| Aug 27, 2007 | ARXT | ↓ Sell | 3,000 | $36.53 | $110K | Direct | Aug 28, 2007 (1d) |
| Jul 25, 2007 | ARXT | ↓ Sell | 3,000 | $39.25 | $118K | Direct | Jul 25, 2007 (0d) |
| Jun 25, 2007 | ARXT | ↓ Sell | 3,000 | $40.51 | $122K | Direct | Jun 26, 2007 (1d) |
| May 25, 2007 | ARXT | ↓ Sell | 3,000 | $39.99 | $120K | Direct | May 29, 2007 (4d) |
| Apr 25, 2007 | ARXT | ↓ Sell | 3,000 | $37.60 | $113K | Direct | Apr 25, 2007 (0d) |
| Apr 4, 2007 | ARXT | ↓ Sell | 3,000 | $35.00 | $105K | Direct | Apr 5, 2007 (1d) |
| Mar 1, 2007 | ARXT | ↓ Sell | 2,000 | $35.75 | $72K | Direct | Mar 2, 2007 (1d) |
| Feb 1, 2007 | ARXT | ↓ Sell | 2,000 | $44.89 | $90K | Direct | Feb 2, 2007 (1d) |
| Jan 3, 2007 | ARXT | ↓ Sell | 2,000 | $40.87 | $82K | Direct | Jan 5, 2007 (2d) |
| Dec 1, 2006 | ARXT | ↓ Sell | 2,000 | $39.34 | $79K | Direct | Dec 4, 2006 (3d) |
| Nov 1, 2006 | ARXT | ↓ Sell | 2,000 | $42.66 | $85K | Direct | Nov 2, 2006 (1d) |
| Oct 2, 2006 | ARXT | ↓ Sell | 2,000 | $35.84 | $72K | Direct | Oct 4, 2006 (2d) |
| Sep 1, 2006 | ARXT | ↓ Sell | 2,000 | $40.61 | $81K | Direct | Sep 1, 2006 (0d) |
| Aug 1, 2006 | ARXT | ↓ Sell | 2,000 | $42.95 | $86K | Direct | Aug 3, 2006 (2d) |
| Jul 3, 2006 | ARXT | ↓ Sell | 2,000 | $44.09 | $88K | Direct | Jul 6, 2006 (3d) |
| Jun 1, 2006 | ARXT | ↓ Sell | 2,000 | $46.01 | $92K | Direct | Jun 5, 2006 (4d) |
| May 1, 2006 | ARXT | ↓ Sell | 2,000 | $42.47 | $85K | Direct | May 2, 2006 (1d) |
| Apr 3, 2006 | ARXT | ↓ Sell | 2,000 | $39.31 | $79K | Direct | Apr 4, 2006 (1d) |
| Dec 8, 2005 | ARXT | ↓ Sell | 34,890 | $43.75 | $1.5M | Direct | Dec 12, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert Daniel Casale's insider trades
Robert Daniel Casale is Chief Operating Officer at Adams Respiratory Therapeutics (ARXT). Since Dec 8, 2005, Robert has reported no open-market purchases and 23 sales worth $3.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (23 filings), grants and awards (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARXT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.